au.\*:("BRUNNER, H. R")
Results 1 to 25 of 211
Selection :
Geographie und Wissenschaft. Wissenschaftstheoretische Anmerkungen und Literaturhinweise Géographie et science. Remarques et indications bibliographiques épistémologiquesBRUNNER H. R.Geographische Rundschau. 1978, Vol 30, Num 2, pp 58-59Article
ACE inhibitors in renal diseaseBRUNNER, H. R.Kidney international. 1992, Vol 42, Num 2, pp 463-479, issn 0085-2538Conference Paper
Rahmenbedingungen und Investitionsentscheidung = New continuous evaporating crystallisation with vapour compression at the Aarberg sugar factory and refinery. I: Background conditions leading to investmentBRUNNER, H. R.Zuckerindustrie. 1992, Vol 117, Num 6, pp 443-445, issn 0344-8657Article
Les antagonistes de l'angiotensine. II: Une classe thérapeutique à part = Angiotensin II antagonists : A special therapeutic classWAEBER, B; BRUNNER, H. R.La Presse médicale (1983). 1996, Vol 25, Num 32, pp 1533-1535, issn 0755-4982Article
Angiotensin II receptor antagonistsBURNIER, M; BRUNNER, H. R.Lancet (British edition). 2000, Vol 355, Num 9204, pp 637-645, issn 0140-6736Article
Angiotensin II antagonists : A new class of antihypertensive agentWAEBER, B; BRUNNER, H. R.British journal of clinical practice. 1996, Vol 50, Num 5, pp 265-269, issn 0007-0947, 4 p.Article
Comparative antihypertensive effects of angiotensin II receptor antagonistsBURNIER, M; BRUNNER, H. R.Journal of the American Society of Nephrology. 1999, Vol 10, pp S278-S282, issn 1046-6673, SUP12Article
Antagonistes des récepteurs AT1 de l'angiotensine II: développement clinique et perspectives futures : Actualités sur le Système Rénine-Angiotensine-Aldostérone = Angiotensin II receptor antagonists: clinical development and future perspectivesBURNIER, M; BRUNNER, H. R.Thérapie (Paris). 1998, Vol 53, Num 3, pp 279-284, issn 0040-5957Article
L'hypokaliémie induite par les diurétiques : Un risque de mort subite pour le malade hypertendu ? = Diuretic-induced hypokaliemia : An increased risk of sudden death for the hypertensive patient ?WAEBER, B; BRUNNER, H. R.Médecine et hygiène. 1997, Vol 55, Num 2155, pp 542-543, issn 0025-6749Article
Introduction to the use of ambulatory blood pressure in therapeutic evaluationsBRUNNER, H. R.Journal of hypertension. 1991, Vol 9, issn 0263-6352, p. S51, SUP3Conference Paper
Endothelin inhibition as a biologic target for treating hypertensionBRUNNER, H. R.American journal of hypertension. 1998, Vol 11, Num 4, pp 103S-109S, issn 0895-7061, 3Article
Hypertension artérielle. Le losartan : une nouvelle manière de bloquez le système rénine-angiotensine chez le malade hypertendu = Treatment of hypertension with losartran, an angiotensin II antagonistWAEBER, B; BURNIER, M; BRUNNER, H. R et al.Médecine et hygiène. 1996, Vol 54, Num 2100, pp 96-98, issn 0025-6749Article
Inhibitors of the renin-angiotensin systemBRUNNER, H. R; NUSSBERGER, J; WAEBER, B et al.Arzneimittel-Forschung. 1993, Vol 43, Num 2A, pp 274-278, issn 0004-4172Conference Paper
Energietechnik und Wärmewirtschaft der Zuckerfabrik + Raffinerie Aarberg AG = III: Energy engineering and heat economy of the Aarberg sugar factoryBRUNNER, H. R; GECKERT, K; FRANKENFELD, TH et al.Zuckerindustrie. 1992, Vol 117, Num 6, pp 454-458, issn 0344-8657Article
Qu'est-ce que les inhibiteurs de l'enzyme de conversion nous ont appris sur le système rénine-angiotensine ? = What have we learned from the ACE inhibitorsWAEBER, B; NUSSBERGER, J; BRUNNER, H. R et al.La Revue du praticien (Paris). 1992, Vol 42, Num 20, pp 2529-2532, issn 0035-2640Article
Hypertension. Les effets protecteurs du traitement antihypertenseur : Nouvelles données : Acquisitions thérapeutiques 1998 (II) = Cardioprotective effects of antihypertensive therapyWAEBER, B; BURNIER, M; BRUNNER, H. R et al.Médecine et hygiène. 1999, Vol 57, Num 2238, pp 88-91, issn 0025-6749, 3 p.Article
Méthodes d'évaluation non invasives chez le malade hypertendu = Noninvasive evaluation method of hypertensive patientsWAEBER, B; NUSSBERGER, J; BRUNNER, H. R et al.Annales de cardiologie et d'angéiologie (Paris). 1987, Vol 36, Num 10, pp 527-532, issn 0003-3928Conference Paper
Isolated perfused mesenteric arteries of hypertensive and normotensive rats; response to norepinephrine, lysine vasopressin and angiotensin IISCHLEGEL, P. A; MONNEY, M; BRUNNER, H. R et al.Clinical and experimental hypertension. Part A, Theory and practice. 1985, Vol 7, Num 11, pp 1583-1596, issn 0730-0077Article
Influence of sodium diet and deoxycorticosterone on the response to norepinephrine, lysine-vasopressin and angiotensin II of isolated perfused rat mesenteric arteriesMONNEY, M; SCHLEGEL, P. A; BRUNNER, H. R et al.Clinical and experimental hypertension. Part A, Theory and practice. 1983, Vol 5, Num 10, pp 1735-1747, issn 0730-0077Article
The new oral angiotensin II antagonist olmesartan medoxomil: a concise overviewBRUNNER, H. R.Journal of human hypertension. 2002, Vol 16, pp S13-S16, issn 0950-9240, SUP2Conference Paper
Mesure de la pression artérielle: meilleur moyen d'évaluer le risque cardiovasculaire ? = Measuring the blood pressure. The best way to assess cardiovascular risk?WAEBER, B; BRUNNER, H.-R.Archives des maladies du coeur et des vaisseaux. 1997, Vol 90, pp 11-13, issn 0003-9683, NS5Conference Paper
Angiotensin-converting enzyme inhibition versus blockade of the renin-angiotensin systemBRUNNER, H. R; WAEBER, B; NUSSBERGER, J et al.The American journal of medicine. 1989, Vol 87, Num 6B, pp 15S-18S, issn 0002-9343Conference Paper
Does renin determine the blood pressure response to calcium entry blockers?WAEBER, B; NUSSBERGER, J; BRUNNER, H. R et al.Hypertension (Dallas, Tex. 1979). 1985, Vol 7, Num 2, pp 223-227, issn 0194-911XArticle
Hypertensive crisis treated with orally administered captoprilBIOLLAZ, J; WAEBER, B; BRUNNER, H. R et al.European journal of clinical pharmacology. 1983, Vol 25, Num 2, pp 145-149, issn 0031-6970Article
Pkasma kinins increase after angiotensin-converting enzyme inhibition in human subjectsPELLACANI, A; BRUNNER, H. R; NUSSBERGER, J et al.Clinical science (1979). 1994, Vol 87, Num 5, pp 567-574, issn 0143-5221Article